U.S. market Closed. Opens in 1 hour 34 minutes

BRTX | BioRestorative Therapies, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Revenue145.80K119.80K46.00K77.00K130.00K111.00K81.00K36.35K628.91K416.00K1.68K15.59KN/AN/A
Cost of Revenue165.74K280.67K205.21KN/AN/AN/AN/A102.00261.50K213.83K208.001.31KN/AN/A
Gross Profit-19.93K-160.87K-159.21K77.00K130.00K111.00K81.00K36.25K367.41K202.16K1.47K14.28KN/AN/A
Operating Expenses15.37M18.98M26.35M2.83M8.56M7.76M8.46M7.83M7.54M5.12M4.75M5.59M3.55M2.07M
Selling, General & Admin11.33M15.58M25.62M1.95M6.84M6.25M6.30M4.95M5.43M3.69M3.16M5.17M3.54M2.06M
Research & Development4.03M3.51M729.06K876.83K1.72M1.51M2.15M2.88M2.11M1.43M1.59M416.18K12.00K11.62K
Other Operating ExpensesN/A-110.52K-16.18M-658.15K-1.87M-1.42MN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-15.22M-18.97M-26.31M-2.75M-8.43M-7.65M-8.37M-7.80M-7.17M-4.92M-4.75M-5.57M-3.55M-2.07M
Other Expenses / Income4.80M479.26K-18.00M-8.52M-6.22M-1.65M-1.07M-839.03K-753.12K-665.11K-998.92K-964.27K-261.92K-170.31K
Before Tax Income-10.42M-18.49M-44.30M-11.27M-14.65M-12.52M-9.44M-8.64M-7.92M-5.59M-5.75M-6.54MN/AN/A
Income Tax Expenses-5.00-479.26K-14.36M981.99K3.27M-1.65MN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-10.42M-18.02M-29.94M-12.25M-17.92M-12.52M-9.44M-8.64M-7.92M-5.59M-5.75M-6.54M-4.07M-2.26M
Interest ExpensesN/A11.65K1.82M1.64M5.14M3.22M1.09M763.94K263.58K285.27K371.28K591.81K260.01K24.16K
Basic Shares Outstanding4.22M3.62M1.19M394.70K5.57K2.93K1.53K1.17K827.00424.00238.00186.00151.001.07K
Diluted Shares Outstanding4.22M3.62M1.19M394.70K5.57K2.93K1.53K1.17K827.00424.00238.00186.00151.001.07K
EBITDA-15.06M-18.99M-42.40M-3.29M-10.08M-8.82M-8.10M-7.61M-7.45M-5.21M-5.28M-5.85M-3.20M-1.85M
EBITDA Margin-10,325.82%-15,853.89%-92,171.35%-4,271.23%-7,754.20%-7,948.86%-9,997.56%-20,943.26%-1,183.96%-1,251.37%-313,994.17%-37,555.36%0.00%0.00%
EBIT-10.42M-18.48M-42.49M-9.63M-9.51M-10.94M-8.36M-7.87M-7.66M-5.30M-5.38M-5.94M-3.81M-2.24M
EBIT Margin-7,145.21%-15,428.31%-92,365.06%-12,509.79%-7,314.50%-9,859.82%-10,317.63%-21,654.10%-1,217.95%-1,274.61%-320,232.92%-38,135.28%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙